DNTH - Dianthus Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$115.00
DETAILS
HIGH:
$145.00
LOW:
$55.00
MEDIAN:
$120.00
CONSENSUS:
$115.00
UPSIDE:
14.50%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-09 | Savitz Ryan | officer: EVP, CFO & CBO | SELL | 10,354 | $100.22 | $1.0M |
| 2026-07-09 | Savitz Ryan | officer: EVP, CFO & CBO | SELL | 15,329 | $101.24 | $1.6M |
| 2026-07-09 | Savitz Ryan | officer: EVP, CFO & CBO | M-Exempt | 31,249 | $21.77 | $680K |
| 2026-07-09 | Savitz Ryan | officer: EVP, CFO & CBO | SELL | 5,566 | $101.97 | $568K |
| 2026-06-17 | Veness Adam M | officer: SVP, General Counsel and Sec. | M-Exempt | 30,000 | $17.88 | $536K |
| 2026-06-17 | Veness Adam M | officer: SVP, General Counsel and Sec. | SELL | 16,771 | $80.34 | $1.3M |
| 2026-06-17 | Veness Adam M | officer: SVP, General Counsel and Sec. | SELL | 13,229 | $81.38 | $1.1M |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | M-Exempt | 9,375 | $22.07 | $207K |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | SELL | 5,428 | $89.72 | $487K |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | M-Exempt | 3,998 | $8.44 | $34K |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | SELL | 4,159 | $91.37 | $380K |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | M-Exempt | 6,908 | $17.88 | $124K |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | M-Exempt | 6,249 | $21.77 | $136K |
| 2026-06-01 | Randhawa Simrat | officer: EVP, Head of R&D | SELL | 16,943 | $90.72 | $1.5M |
| 2026-05-21 | Violin Jonathan | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-21 | Romano Steven J. | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-21 | Read Simon | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-21 | McGeorge Anne | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-21 | KANGO SUJAY | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-21 | Soteropoulos Paula | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-21 | Lawton Alison Frances | director | A-Award | 6,090 | $89.63 | $546K |
| 2026-05-08 | Soteropoulos Paula | director | SELL | 599 | $85.47 | $51K |
| 2026-05-08 | Soteropoulos Paula | director | M-Exempt | 599 | $8.44 | $5K |
| 2026-04-09 | Savitz Ryan | officer: EVP, CFO & CBO | SELL | 8,224 | $89.84 | $739K |
| 2026-04-09 | Savitz Ryan | officer: EVP, CFO & CBO | M-Exempt | 8,224 | $17.88 | $147K |